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Abstract CYP61 was revealed in the sequencing of the yeast 
genome on chromosome XIII and was the last member of the 
CYP superfamily in yeast to be discovered. We show here that 
besides the housekeeping role in 22-desaturation during ergo-
sterol biosynthesis the enzyme is also that responsible for 
benzo(a)pyrene metabolism/proniutagen activation by yeast in 
genotoxicity assays. This enzyme may represent an ancestral 
activity for the superfamily which allowed xenobiotic metabolism 
for the first time. 
© 1997 Federation of European Biochemical Societies. 
1. Introduction 
In eukaryotic organisms lipophilic compounds, such as 
many natural products and synthetic compounds including 
drugs, carcinogens and pesticides, cannot be excreted unless 
they are oxidised to more polar compounds. These oxidation 
reactions are primarily carried out by the superfamily of cy-
tochrome P450-dependent monooxygenases (for review: [1]). 
Some cytochrome P450s (CYPs) have evolved to fulfil a role 
in detoxification, while others are involved in biosynthetic 
reactions leading to the production of sterols, steroids, ter-
penes, flavenoids, alkaloids and other products. These latter 
enzymes are associated with tight substrate specificity unlike 
many of the detoxification enzymes. F r o m an evolutionary 
viewpoint the discovery that CYP51, sterol 14a-demethylase, 
was the first family present in different Kingdoms points to 
sterol biosynthesis (Fig. 1) as an ancient function for the 
superfamily [2] and we have been interested in the activity 
of the second CYP enzyme involved in sterol biosynthesis, 
CYP61, a 22-desaturase [3]. 
The inherent ability of Saccharomyces cerevisiae to metab-
olise promutagens/procarcinogens has been extensively 
studied in genotoxicity tests and includes among other com-
pounds benzo(a)pyrene [4]. For detection of mutagenicity 
physiological manipulation of the tester strains was undertak-
en to increase endogenous yeast cytochrome P450. However, 
controversy over this activity has existed and the role of cy-
tochrome P450 has remained unresolved. Yoshida and Aoya-
ma [5] have not observed benzo(a)pyrene binding or metabo-
lism with purified sterol 14oc-demethylase (CYP51) which we 
have confirmed for the human and plant enzymes (unpub-
lished observation). Recently we have purified and character-
ised the second cytochrome P450 of vegetative S. cerevisiae, 
CYP61, undertaking sterol A22-desaturation [3,6]. This activity 
is present in organisms from different Kingdoms including 
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protozoa, algae, plants and fungi and confers resistance to 
osmotic stress on organisms containing 22-desaturated sterol 
in their membranes [7]. Here we show CYP61 to be the ben-
zo(a)pyrene hydroxylase enzyme from yeast, characterise its 
enzymatic properties and speculate on the importance of ac-
quiring xenobiotic metabolism activities during evolution of 
the superfamily. 
2. Materials and methods 
2.1. Materials 
Microsomes were prepared and CYP61 was purified from semi-
anaerobically grown cells of the Saccharomyces cerevisiae cyp51 
gene disrupted strain DK2 (AP45051; ergll) [5]. Ergosta-5,7-dienol 
was purified from a polyene-resistant erg5 mutant of S. cerevisiae 
(A22-desaturase defective) as described previously [6]. Unless specified 
all chemicals were obtained from Sigma Chemical Co., Poole, Dorset. 
2.2. Reconstitution of benzo(a)pyrene metabolism 
Benzo(a)pyrene hydroxylase activity was measured using the aryl 
hydrocarbon hydroxylase assay according to the modified method of 
King et al. [8,10]. CYP61 (0.5 nmol), 1 U NADPH cytochrome P450 
reductase, 23 nM NADPH and varying concentrations of benzo(a)-
pyrene, dissolved in dimethylsulphoxide (DMSO) were incubated at 
37°C, for 20 min. The reaction was terminated by the addition of ice-
cold acetone and precipitated protein removed by centrifugation. Ali-
quots (0.6 ml) of the supernatant were added to 1.4 ml triethylamine 
(8.5%) in water and this mixture was centrifuged to remove any res-
idual precipitate. Fluorescence was measured at 467 nm excitation, 
525 nm emission. Controls using boiled enzyme and without the ad-
dition of NADPH were carried out at each benzo(a)pyrene concen-
tration. Assays were calibrated using a quinine sulphate standard with 
reference to 3-hydroxybenzo(a)pyrene standards according to Nebert 
and Gelboin [10]. Activity was measured using a Perkin Elmer 3000 
fluorescence spectrophotometer. 
2.3. Reconstitution of sterol A22-desaturase activity 
The standard reaction mixture contained purified P45061 (0.5 
nmol), 1 U of rabbit NADPH cytochrome P450 reductase, varying 
concentrations of ergosta-5,7-dienol dispersed in 80 nmol dilauroyl-
phosphatidylcholine (DLPC) and the reaction volume adjusted to 950 
u.1 with 100 mM potassium phosphate buffer, pH 7.2. NADPH was 
added at a concentration of 23 mM to the mixture to start the reac-
tion. All reactions were incubated at 37°C for 20 min in a shaking 
water bath. Reactions were stopped by the addition of 3 ml methanol, 
and the sterols extracted using 2 ml (0.5% w/v) of pyrogallol in meth-
anol and 2 ml of 60% potassium hydroxide (in water), incubated at 
90°C for 2 h in a preheated water bath. After cooling the saponified 
mixture was extracted with 3 X 5 ml hexane and dried under nitrogen. 
A Hewlett/Packard GC/MS was used to confirm sterol identities. An 
Ultra 1 capillary column was used (10 mX0.2 i.d.) on a temperature 
programme 50°C (1 min) increased by 40°C/min to 290°C with a run 
time of 17 min. Injection port temperature was 280°C (splitless) and 
the carrier gas was helium at 40 kPa. Trimethylatedsilylated deriva-
tives of ergosta-5,7-dienol and the A22-desaturated metabolite (ergo-
sterol) were clearly separated as two distinct peaks [6]. The conversion 
ratio was calculated from the areas of the two peaks and the activity 
(nmol ergosterol formed/min) was obtained from the amount of ergo-
sta-5,7-dienol added and the conversion ratio. Linear regression was 
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used in double reciprocal plots of these and other activity measure-
ments. 
2.4. Inhibition of reconstituted sterol A22-desaturase activity by 
benzo(a)pyrene 
Ergosta-5,7-dienol at varying concentrations was metabolised 
aerobically by purified CYP61 in the reconstituted system described 
above. Benzo(a)pyrene at varying concentrations was added to the 
reconstituted system in DMSO; control assays received DMSO alone. 
Ergosta-5,7-dienol and its metabolite, ergosterol, were analysed by 
GC/MS as described above. Values are the means of triplicate deter-
minations. 
3. Results and discussion 
CYP61 was capable of benzo(a)pyrene metabolism as meas-
ured by the production of 3-hydroxybenzo(a)pyrene (Fig. 2). 
Fig. 3 shows that the CYP61 reconstituted system has a Fmax 
of 1.0 nmol 3-hydroxybenzo(a)pyrene formed h _ 1 per nmol 
CYP61 and a KM of 50.1 uM. The Vmax of 1 nmol h"
1 per 
HO 
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Fig. 1. The biosynthetic steps undertaken by CYP51 and CYP61 
during ergosterol biosynthesis. 
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Fig. 2. The cytochrome P450 mediated metabolism of benzo(a)pyr-
ene to 3-hydroxybenzo(a)pyrene. 
nmol P45061 was also comparable to the value of 1.1 nmol 
h _ 1 per nmol P450 obtained by King et al. [8] who purified a 
benzo(a)pyrene hydroxylase which produced mutagenic me-
tabolites from a brewing strain of yeast, but could not identify 
an endogenous function for the protein. Benzo(a)pyrene hy-
droxylation was shown to be dependent on CYP61, NADPH 
cytochrome P450 reductase and NADPH. Benzo(a)pyrene 
was also shown to be a competitive inhibitor of A22-desatura-
tion (Fig. 4) with the inhibition constant, Kit determined to be 
50.2 uM (IC50 = 82 uM). 
The successful identification of CYP61 as the benzo(a)pyr-
ene hydroxylase of yeast resolves the question as to the ability 
of yeast genotoxicity assays to activate procarcinogens. 
CYP61 is a low activity enzyme operating with a Vmax about 
180-fold lower than for sterol 22-desaturation [3]. The procar-
cinogens activated include various xenobiotics including afla-
toxins, dimethylnitrosamine and various cyclopenta(a) phen-
anthrenes and the enzyme may be responsible for the rather 
higher benzo(a)pyrene turnover observed in microsomes of 
fungi used in bioremediation [9]. Sterol 22-desaturase is the 
first fungal cytochrome P450 correlated with activity in ben-
zo(a)pyrene metabolism. 
Sterol 22-desaturation is found in diverse Kingdoms includ-
ing algae, protozoa, plants and fungi, but not mammals, 
whereas CYP51, sterol 14oc-demethylase, is present in animals, 
protists, plants, fungi and probably some bacteria. In consid-
ering the evolution of the CYP superfamily, at least in eukar-
yotes, it appears reasonable to suggest that CYP61 diverged 
from CYP51 during the first events, conferring osmotic toler-
ance on primitive unicellular organisms. In acquiring xenobi-
otic metabolism this may have allowed the initial selection of 
new enzymes with detoxifying capabilities. Subsequently, the 
wide array of P450 enzymes seen today may have come about 
through evolution from CYP61. In animals the need for the 
endogenous role of the enzyme may have become lost with the 
emergence of homeostasis or other compensating modifica-
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Fig. 3. Double reciprocal plot of benzo(a)pyrene metabolite forma-
tion (□) vs. substrate concentration using purified CYP61. 
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of the xenobiotic metabolising CYP isozymes came about 
from this CYP51-»CYP61 divergent step. 
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Fig. 4. Effect of benzo(a)pyrene (A) on CYP61 mediated ergosta-
5,7-dienol A22-desaturation. Benzo(a)pyrene was added at half equi-
molar concentration with respect to CYP61. (□) represents kinetic 
analysis of endogenous sterol A22-desaturation as catalysed by 
CYP61. Values are the means of triplicate determinations. 
tions which alter the requirements for membrane structure/ 
function. Thus we propose that the first step in the production 
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